REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/05/2025
Voltar para busca
Dado oficial do USPTO
SMARTPHLEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SMARTPHLEX
ST13
US500000079250945Classe
9, 35, 40, 42, 44
Pedido
79250945
Registro
6060922
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
27/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 40, 42, 44
Data de depósito
02/07/2018
Data de registro
26/05/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/05/2020
Última transação
27/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
DE
Examinador
CHOE, JULIE
Unidade examinadora
N80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
PharmaLex GmbH
Representantes
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Software for supporting product development processes and regulatory compliance; software for automation of routine processes and report generation; artificial intelligence software for supporting decision making processes; computer programs for data processing; downloadable computer software applications for supporting product development processes and regulatory compliance; unified communications software for supporting decision making processes; assistive software for supporting product development processes and regulatory compliance; all the foregoing in the fields of medical devicesconsumer healthcareanimal healthcarepharmaceuticals and biopharmaceuticals
Classe 35
Advertising servicesbusiness management for otherscompany administration in the nature of business administration services; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business assistance and consultancy services in the field of retailing services and wholesaling services related to medicines; provision of outsourcing services in the field of business management for companies engaged in the field of medicine developmentauthorizationproductionsalesafety and monitoring; assistance and consultancy in the field of business management of companies engaged in medicine and medical device authorization and lifecycle maintenanceautomation of content compilation and document dossier developmentautomation for creation of documents for achieving medical marketing authorization and marketing approval; regulatory submission managementassisting others in filing of documents with regulatory authorities for authorizing and lifecycle maintenance of medicines and medical devices using documentsreports and files required by regulatory authorities via automation of content compilation and document dossier developmentautomation for creation of documents for achieving medical marketing authorization and marketing approval
Classe 40
Assistance and consultancy in the context of medicine productionmanufacturing process consulting
Classe 42
Scientific and technological services and research and design relating theretoscientific research and laboratory research in the field of pharmaceuticals; industrial analysis and research serviceslaboratory research services relating to pharmaceuticals and pharmaceutical research services; research and development of new products for others in the field of pharmaceuticals; provision of scientific surveys in the field of pharmaceuticals in the nature of scientific research; development of a web application for inputting and using informative texts for medicines and medical productsin particular user guidespackaging insertsspecialist informationfor providing various documents; database serviceselectronic storage of data in computer databases; conversion of data or documents from physical to electronic media; scientific research; scientific research and analysis in the field of pharmaceuticals; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; medical laboratory services; information technology consultancy services provided to the pharmaceutical and healthcare industries; scientific assessment of the efficiency of medicines; services for assessing the efficiency of pharmaceuticalspharmaceutical product evaluation; new product design servicesanalysis and evaluation of product design; product development consultationanalysis and evaluation of new product development; quality control testing for othersproduct testing; materials testing and evaluation; product safety testing; quality control servicestestinganalysis and evaluation of the services of others to determine conformity with certification standards; quality testing of products for others to determine conformity with certification standards; developmentupdating and maintenance of software and database systems; development of software for data and multimedia content conversion from and to different protocols; Providing temporary use of on-linenon-downloadable software for publishing and printing written materials for improving gains in efficiency with client operations; providing temporary use of on-line non-downloadable software for the management of information; providing temporary use of on-line non-downloadable software for the transmission of information; providing temporary use of on-line non-downloadable software for the transmission of data; providing temporary use of on-line non-downloadable software for the management of data; software as a service (SAAS) services featuring software for the management and transmission of information and data; rental of software for data processing; all the foregoing in the fields of medical devicesconsumer healthcareanimal healthcarepharmaceuticals and biopharmaceuticals
Classe 44
Medical and veterinary medical services; pharmacy advice in the nature of pharmaceutical advice; providing information relating to medicine; providing information relating to the preparation and dispensing of medications; advisory services relating to pharmaceuticalspharmaceutical advice
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/11/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/11/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/09/2020
FIMP
FINAL DISPOSITION PROCESSED
24/09/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
26/05/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2020
PUBO
PUBLISHED FOR OPPOSITION
10/03/2020
GPNX
NOTIFICATION PROCESSED BY IB
06/03/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/02/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
19/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
31/01/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
31/01/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
31/01/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
31/01/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/01/2020
GNFR
FINAL REFUSAL E-MAILED
28/01/2020
CNFR
FINAL REFUSAL WRITTEN
28/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/01/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/09/2019
GNRT
NON-FINAL ACTION E-MAILED
04/09/2019
CNRT
NON-FINAL ACTION WRITTEN
04/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2019
ALIE
ASSIGNED TO LIE
05/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/07/2019
RFNT
REFUSAL PROCESSED BY IB
16/03/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/02/2019
RFRR
REFUSAL PROCESSED BY MPU
21/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/02/2019
CNRT
NON-FINAL ACTION WRITTEN
12/02/2019
MAFR
APPLICATION FILING RECEIPT MAILED
12/02/2019
DOCK
ASSIGNED TO EXAMINER
06/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/02/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SMARTPHLEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.